MobiHealthNews

Insulet gets FDA nod to commercialize Omnipod Dash Insulin Management System

Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash ...
Nasdaq

Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...
Yahoo Finance

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

New 100 mg/dL Target Glucose setting offers more customization and tighter glucose management. Enhanced algorithm helps users remain in Automated Mode to improve the user experience. Most requested ...
Business Wire

Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod® 5 Automated Insulin Delivery System because of ...
Pharmabiz

Ascensia Diabetes Care enters into strategic alliance with Insulet Corporation to connect Contour Next One BGMS and Omnipod Dash PDM

Ascensia Diabetes Care has announced it has entered into a strategic alliance by signing a development agreement with Insulet Corporation, the leader in tubeless insulin pump technology with its ...